Sep 23, 2021
Metabiota Partners with FII Institute and Accenture to Launch the Global Infectious Diseases IndexFII Institute launched a unique global index that uses groundbreaking technology to track infectious diseases and transform how the world reacts to future crises. The Global Infectious Diseases Index was developed by FII Institute in partnership with Accenture and Metabiota. Metabiota's risk solution program was among the first to flag unusual infections in Wuhan in December 2019. For more information, visit the Global Infectious Disease Index and the associated press release.
Jul 31, 2021
How might probability inform policy on pandemics? Metabiota has ideasThere is a 47% to 57% chance the world will experience another pandemic or epidemic that kills at least as many people as COVID-19 in the next 25 years, according to estimates from Metabiota, a San Francisco-based company that tracks infectious disease risks and outbreaks. Metabiota applies catastrophe risk modeling — which allows financial institutions, insurers, and public agencies to understand the likelihood of extreme events and crises, such as wildfires, floods, and earthquakes — to pandemics and epidemics. For more information on Metabiota's application of catastrophe risk modeling, view the full article on Devex.
Jun 15, 2021
Metabiota Awarded as Technology Pioneer by World Economic ForumThe World Economic Forum announced its selection of the 100 most promising Technology Pioneers of 2021 – companies that are shaping industries from healthcare to retail and many more. This year’s cohort includes representation from 26 economies on six continents with reach far beyond traditional tech hubs like Silicon Valley. Metabiota, the global pioneer in infectious disease risk solutions, made it to the selection for its contributions in the field of infectious disease analytics and risk management The full list of Technology Pioneers can be viewed here and press release can be viewed here.
Feb 24, 2021
New Case Study on Metabiota's Epidemic Detection SystemMetabiota has released a new case study after Metabiota’s early insights into the COVID-19 pandemic provided critical data to make operational decisions. According to Eran Ben-Shushan, CEO of the events software company Bizzabo, “Metabiota provided crucial early warning about the potential effects of the COVID pandemic in January 2020, prompting Bizzabo to make an early pivot from in-person to online events. This led to 100%+ growth in revenue for the year, rather than the extreme losses that many in the in-person events industry have faced.” Read the full story in this case study.
Dec 03, 2020
Metabiota in Modern Insurance Magazine: Industry Innovators InterviewMetabiota’s mission is to make the world more resilient to epidemics. Following the impact of Covid-19, change is on the horizon as the need to cover risk becomes ever more prevalent. Nita Madhav, CEO of Metabiota, discusses Metabiota’s work and ability to mitigate against the outbreaks. Epidemic risk factors will only continue to escalate across the globe, and Metabiota is working hard to inform the industry of the data and tools available that could help them mitigate against future epidemic and pandemic risks and their consequences. View full article in Modern Insurance Magazine.
Oct 16, 2020
Metabiota in the Cameroon Tribune: MINDEF: Minister Encourages Army Health Research CentreThe Minister Delegate at the Presidency in charge of Defence, Joseph Beti Assomo paid a working visit to the Army Health Research Centre (CRESAR) and Metabiota teams on October 15, 2020, a culmination of 20 years of successful collaborative efforts. CRESAR began in 2000 with a mission to carry out research and laboratory testing for the Defence Forces, their families, and other populations in Cameroon. Together with Metabiota, CRESAR has contributed enormously to public health in the military and general Cameroonian population. View full article in Cameroon Tribune.
Sep 25, 2020
Metabiota in Homeland Preparedness News: Bipartisan Commission on Biodefense prepares for next pandemicThe ongoing COVID-19 pandemic is revealing major gaps in national readiness to prepare for, respond to, and recover from biological threats, requiring that decision makers consider improved policies, programs, and technologies to ramp up the federal defense, experts said during the Sept. 24 virtual meeting of the Bipartisan Commission on Biodefense. View article for more information on the Bipartisan Commission on Biodefense and Metabiota.
Sep 21, 2020
Metabiota in S&P Global Market Intelligence: Human behavior biggest challenge in race to model pandemic riskCapturing how individuals and governments respond to pandemics is one of the key challenges to developing risk models that could underpin future insurance solutions, according to specialists. View article in S&P Global Market Intelligence: Human behavior biggest challenge in race to model pandemic risk
Jul 30, 2020
Metabiota in Insurance Day: Not so unexpected? Modelling pandemic risksIt is possible for insurers and clients to estimate potential losses caused by events like Covid-19, the chief executive of San Francisco-based Metabiota says... View article in Insurance Day: Not so unexpected? Modelling pandemic risks
Jul 01, 2020